Internal Medicine, Rheumatology · Miami Beach, FL
NPI
1659304707
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4302 Alton Rd, Suite 550
Miami Beach, FL, 33140
Phone (305) 531-6766
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
94,688 services
Medicare patients, 2024
647
Average age 77
Drug cost, 2024
$3.9M
3,244 prescriptions
Company payments, 2025
$61K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos A Sesin was code J0897 (injection, denosumab, 1 mg), 24,120 times for 237 patients. In total Carlos A Sesin billed 94,688 services in 46 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 24,120 | 237 | $19.18 | $463K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,586 | 32 | $0.10 | $160 |
| 99214 Office E&M - Established | Office | 920 | 538 | $99.17 | $91K |
| 96401 Chemotherapy Administration | Office | 778 | 274 | $56.17 | $44K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 280 | 56 | $5.06 | $1,416 |
| 20610 Joint Injection | Office | 170 | 72 | $56.01 | $9,521 |
| 99213 Office E&M - Established | Office | 151 | 106 | $71.37 | $11K |
| J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 131 | 55 | $543.69 | $71K |
| 99204 Office E&M - New | Office | 103 | 103 | $132.97 | $14K |
| 96413 Chemotherapy Administration | Office | 102 | 24 | $103.37 | $11K |
| 36415 Venipuncture Blood Collection | Office | 79 | 61 | $8.65 | $683 |
| 96365 Intravenous Infusion, Hydration | Office | 58 | 58 | $51.65 | $2,996 |
| 20611 Joint Injection | Office | 20 | 17 | $81.01 | $1,620 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 19 | 17 | $4.51 | $85.66 |
| 99212 Office E&M - Established | Office | 13 | 13 | $36.38 | $473 |
By year: 2022 $1.5M for 137,779 services; 2023 $1.1M for 93,071 services; 2024 $1.2M for 94,688 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 79 | 61 | $8.65 | $683 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos A Sesin prescribed most often to Medicare patients was Prednisone, with 541 prescriptions and refills. In total Carlos A Sesin wrote 3,244 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 541 | 738 | 148 | $3,276 |
| Prolia Denosumab | 388 | 2,316 | 228 | $678K |
| Alendronate Sodium Generic | 319 | 877 | 104 | $2,843 |
| Methotrexate Methotrexate Sodium | 316 | 730 | 83 | $6,381 |
| Folic Acid Generic | 119 | 320 | 40 | $757 |
| Diclofenac Sodium Generic | 106 | 125 | 37 | $3,827 |
| Hydroxychloroquine Sulfate Generic | 75 | 207 | 26 | $2,282 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 67 | 166 | 23 | $535 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 65 | 65 | 14 | $159K |
| Allopurinol Generic | 63 | 159 | 19 | $452 |
| Xeljanz Xr Tofacitinib Citrate | 55 | 55 | Under 11 | $313K |
| Enbrel Sureclick Etanercept | 53 | 53 | Under 11 | $389K |
| Taltz Autoinjector Ixekizumab | 50 | 50 | Under 11 | $333K |
| Leflunomide Generic | 50 | 138 | 15 | $2,164 |
| Meloxicam Generic | 46 | 52 | 15 | $124 |
Brand drugs: - claims; generic drugs: 2,302 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos A Sesin $61K ($58K in general payments such as food, travel and fees and $3,029 for research) from 23 companies. The largest payer was Janssen Biotech, Inc. with $51K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 49 | $51K |
| Eli Lilly and Company LLY | 1 | $3,029 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $1,356 |
| Amgen Inc. AMGN | 22 | $1,050 |
| Abbvie Inc. ABBV | 35 | $954 |
| Lilly USA, LLC LLY | 2 | $918 |
| Merck Sharp & Dohme LLC MRK | 5 | $773 |
| UCB, Inc. UCB.BR | 23 | $553 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $376 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $225 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.